{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T23:42:44Z","timestamp":1788392564895,"version":"build-2803163510"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2017,9,8]],"date-time":"2017-09-08T00:00:00Z","timestamp":1504828800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1245\/s10434-017-6082-1","type":"journal-article","created":{"date-parts":[[2017,9,11]],"date-time":"2017-09-11T11:50:24Z","timestamp":1505130624000},"page":"768-775","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":55,"title":["Long-Term Follow-Up of Desmoid Fibromatosis Treated with PF-03084014, an Oral Gamma Secretase Inhibitor"],"prefix":"10.1245","volume":"25","author":[{"given":"Victor Manuel","family":"Villalobos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francis","family":"Hall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Jimeno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lia","family":"Gore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth","family":"Kern","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rossano","family":"Cesari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey T.","family":"Schowinsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick Judson","family":"Blatchford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brianna","family":"Hoffner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Elias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wells","family":"Messersmith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,9,8]]},"reference":[{"issue":"1","key":"6082_CR1","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1200\/JCO.1999.17.1.158","volume":"17","author":"MT Ballo","year":"1999","unstructured":"Ballo MT, Zagars GK, Pollack A, Pisters PW, Pollack RA. Desmoid tumor: prognostic factors and outcome after surgery, radiation therapy, or combined surgery and radiation therapy. J Clin Oncol. 1999;17(1):158\u201367. doi: 10.1200\/JCO.1999.17.1.158 .","journal-title":"J Clin Oncol"},{"key":"6082_CR2","doi-asserted-by":"crossref","unstructured":"Lewis JJ, Boland PJ, Leung DH, Woodruff JM, Brennan MF. The enigma of desmoid tumors. Ann Surg. 1999;229(6):866\u201372 (discussion 872\u20133).","DOI":"10.1097\/00000658-199906000-00014"},{"issue":"5","key":"6082_CR3","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1097\/SAP.0b013e3182084cf6","volume":"67","author":"RN Berri","year":"2011","unstructured":"Berri RN, Baumann DP, Madewell JE, Lazar A, Pollock RE. Desmoid Tumor. Ann Plast Surg. 2011;67(5):551\u201364. doi: 10.1097\/SAP.0b013e3182084cf6 .","journal-title":"Ann Plast Surg"},{"issue":"13","key":"6082_CR4","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1200\/JCO.2006.10.5015","volume":"25","author":"D Lev","year":"2007","unstructured":"Lev D, Kotilingam D, Wei C, et al. Optimizing treatment of desmoid tumors. J Clin Oncol. 2007;25(13):1785\u201391. doi: 10.1200\/JCO.2006.10.5015 .","journal-title":"J Clin Oncol"},{"issue":"1","key":"6082_CR5","doi-asserted-by":"publisher","first-page":"60","DOI":"10.3109\/08880018.2014.956905","volume":"32","author":"N Woltsche","year":"2015","unstructured":"Woltsche N, Gilg MM, Fraissler L, et al. Is wide resection obsolete for desmoid tumors in children and adolescents? Evaluation of histological margins, immunohistochemical markers, and review of literature. Pediatr Hematol Oncol. 2015;32(1):60\u20139. doi: 10.3109\/08880018.2014.956905 .","journal-title":"Pediatr Hematol Oncol"},{"issue":"3","key":"6082_CR6","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1002\/jso.20057","volume":"86","author":"A Leithner","year":"2004","unstructured":"Leithner A, Gapp M, Leithner K, et al. Margins in extra-abdominal desmoid tumors: a comparative analysis. J Surg Oncol. 2004;86(3):152\u201356. doi: 10.1002\/jso.20057 .","journal-title":"J Surg Oncol."},{"issue":"1","key":"6082_CR7","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1002\/cncr.24679","volume":"116","author":"C Meazza","year":"2010","unstructured":"Meazza C, Bisogno G, Gronchi A, et al. Aggressive fibromatosis in children and adolescents. Cancer. 2010;116(1):233\u201340. doi: 10.1002\/cncr.24679 .","journal-title":"Cancer"},{"issue":"4","key":"6082_CR8","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/j.ejso.2007.06.006","volume":"34","author":"S Bonvalot","year":"2008","unstructured":"Bonvalot S, Eldweny H, Haddad V, et al. Extra-abdominal primary fibromatosis: aggressive management could be avoided in a subgroup of patients. Eur J Surg Oncol. 2008;34(4):462\u201368. doi: 10.1016\/j.ejso.2007.06.006 .","journal-title":"Eur J Surg Oncol"},{"issue":"26","key":"6082_CR9","doi-asserted-by":"publisher","first-page":"3553","DOI":"10.1200\/JCO.2010.33.5489","volume":"29","author":"SB Salas","year":"2011","unstructured":"Salas SB, Dufresne A, Bui B, et al. Prognostic factors influencing progression-free survival determined from a series of sporadic desmoid tumors: a wait-and-see policy according to tumor presentation. J Clin Oncol. 2011;29(26):3553\u201358. doi: 10.1200\/JCO.2010.33.5489 .","journal-title":"J Clin Oncol."},{"issue":"2","key":"6082_CR10","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1097\/SLA.0b013e31828c8a30","volume":"258","author":"AM Crago","year":"2013","unstructured":"Crago AM, Denton B, Salas SB, et al. A prognostic nomogram for prediction of recurrence in desmoid fibromatosis. Ann Surg. 2013;258(2):347\u201353. doi: 10.1097\/SLA.0b013e31828c8a30 .","journal-title":"Ann Surg"},{"issue":"5","key":"6082_CR11","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.2353\/ajpath.2008.080475","volume":"173","author":"AJF Lazar","year":"2008","unstructured":"Lazar AJF, Tuvin D, Hajibashi S, et al. Specific mutations in the beta-catenin gene (CTNNB1) correlate with local recurrence in sporadic desmoid tumors. Am J Pathol. 2008;173(5):1518\u201327. doi: 10.2353\/ajpath.2008.080475 .","journal-title":"Am J Pathol."},{"issue":"22","key":"6082_CR12","doi-asserted-by":"publisher","first-page":"4088","DOI":"10.1002\/cncr.29564","volume":"121","author":"H Shang","year":"2015","unstructured":"Shang H, Braggio D, Lee Y-J, et al. Targeting the Notch pathway: a potential therapeutic approach for desmoid tumors. Cancer. 2015;121(22):4088\u201396. doi: 10.1002\/cncr.29564 .","journal-title":"Cancer."},{"issue":"4","key":"6082_CR13","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1097\/CCO.0000000000000374","volume":"29","author":"N Penel","year":"2017","unstructured":"Penel N, Chibon FDR, Salas SB. Adult desmoid tumors. Curr Opin Oncol. 2017;29(4):268\u201374. doi: 10.1097\/CCO.0000000000000374 .","journal-title":"Curr Opin Oncol"},{"issue":"1","key":"6082_CR14","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.jss.2016.06.028","volume":"205","author":"JS Park","year":"2016","unstructured":"Park JS, Nakache Y-P, Katz J, et al. Conservative management of desmoid tumors is safe and effective. J Surg Res. 2016;205(1):115\u201320. doi: 10.1016\/j.jss.2016.06.028 .","journal-title":"J Surg Res"},{"key":"6082_CR15","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.ejca.2017.02.001","volume":"76","author":"B Kasper","year":"2017","unstructured":"Kasper B, Gruenwald V, Reichardt P, et al. Imatinib induces sustained progression arrest in RECIST progressive desmoid tumours: final results of a phase II study of the German Interdisciplinary Sarcoma Group (GISG). Eur J Cancer. 2017;76:60\u20137. doi: 10.1016\/j.ejca.2017.02.001 .","journal-title":"Eur J Cancer"},{"issue":"12","key":"6082_CR16","doi-asserted-by":"publisher","first-page":"4082","DOI":"10.1158\/1078-0432.CCR-10-3322","volume":"17","author":"MM Gounder","year":"2011","unstructured":"Gounder MM, Lefkowitz RA, Keohan ML, et al. Activity of sorafenib against desmoid tumor\/deep fibromatosis. Clin Cancer Res. 2011;17(12):4082\u201390. doi: 10.1158\/1078-0432.CCR-10-3322 .","journal-title":"Clin Cancer Res"},{"issue":"7","key":"6082_CR17","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1002\/pbc.24457","volume":"60","author":"SX Skapek","year":"2012","unstructured":"Skapek SX, Anderson JR, Hill DA, et al. Safety and efficacy of high-dose tamoxifen and sulindac for desmoid tumor in children: results of a Children\u2019s Oncology Group (COG) Phase II Study. Pediatr Blood Cancer. 2012;60(7):1108\u201312. doi: 10.1002\/pbc.24457 .","journal-title":"Pediatr Blood Cancer"},{"issue":"5","key":"6082_CR18","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1002\/1097-0142(20010901)92:5<1259::AID-CNCR1446>3.0.CO;2-Y","volume":"92","author":"A Azzarelli","year":"2001","unstructured":"Azzarelli A, Gronchi A, Bertulli R, et al. Low-dose chemotherapy with methotrexate and vinblastine for patients with advanced aggressive fibromatosis. Cancer. 2001;92(5):1259\u201364.","journal-title":"Cancer."},{"issue":"1","key":"6082_CR19","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1093\/annonc\/mdr051","volume":"23","author":"D Garbay","year":"2012","unstructured":"Garbay D, Le Cesne A, Penel N, et al. Chemotherapy in patients with desmoid tumors: a study from the French Sarcoma Group (FSG). Ann Oncol. 2012;23(1):182\u201386. doi: 10.1093\/annonc\/mdr051 .","journal-title":"Ann Oncol"},{"issue":"17","key":"6082_CR20","doi-asserted-by":"publisher","first-page":"2930","DOI":"10.1016\/j.ejca.2009.08.016","volume":"45","author":"A Constantinidou","year":"2009","unstructured":"Constantinidou A, Jones RL, Scurr M, Al-Muderis O, Judson I. Pegylated liposomal doxorubicin, an effective, well-tolerated treatment for refractory aggressive fibromatosis. Eur J Cancer. 2009;45(17):2930\u201334. doi: 10.1016\/j.ejca.2009.08.016 .","journal-title":"Eur J Cancer"},{"issue":"1","key":"6082_CR21","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1158\/1078-0432.CCR-14-0607","volume":"21","author":"WA Messersmith","year":"2015","unstructured":"Messersmith WA, Shapiro GI, Cleary JM, et al. A phase i, dose-finding study in patients with advanced solid malignancies of the oral \u03b3-secretase inhibitor PF-03084014. Clin Cancer Res. 2015;21(1):60\u20137. doi: 10.1158\/1078-0432.CCR-14-0607 .","journal-title":"Clin Cancer Res"},{"issue":"14","key":"6082_CR22","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1200\/JCO.2016.71.1994","volume":"35","author":"S Kummar","year":"2017","unstructured":"Kummar S, O\u2019Sullivan Coyne G, Do KT, et al. Clinical activity of the \u03b3-secretase inhibitor PF-03084014 in adults with desmoid tumors (aggressive fibromatosis). J Clin Oncol. 2017:35(14):1561\u201369. doi: 10.1200\/JCO.2016.71.1994 .","journal-title":"J Clin Oncol"},{"issue":"1","key":"6082_CR23","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.canlet.2015.07.048","volume":"369","author":"X Yuan","year":"2015","unstructured":"Yuan X, Wu H, Xu H, et al. Notch signaling: an emerging therapeutic target for cancer treatment. Cancer Lett. 2015;369(1):20\u20137. doi: 10.1016\/j.canlet.2015.07.048 .","journal-title":"Cancer Lett"},{"issue":"8","key":"6082_CR24","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1038\/nrclinonc.2015.61","volume":"12","author":"N Takebe","year":"2015","unstructured":"Takebe N, Miele L, Harris PJ, et al. Targeting Notch, Hedgehog, and Wnt pathways in cancer stem cells: clinical update. Nat Rev Clin Oncol. 2015;12(8):445\u201364. doi: 10.1038\/nrclinonc.2015.61 .","journal-title":"Nat Rev Clin Oncol"},{"issue":"1","key":"6082_CR25","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1158\/1078-0432.CCR-14-1660","volume":"21","author":"DPM Hughes","year":"2015","unstructured":"Hughes DPM, Kummar S, Lazar AJ. New, tolerable \u03b3-secretase inhibitor takes desmoid down a notch. Clin Cancer Res. 2015;21(1):7\u20139. doi: 10.1158\/1078-0432.CCR-14-1660 .","journal-title":"Clin Cancer Res"},{"issue":"22","key":"6082_CR26","doi-asserted-by":"publisher","first-page":"3933","DOI":"10.1002\/cncr.29562","volume":"121","author":"MM Gounder","year":"2015","unstructured":"Gounder MM. Notch inhibition in desmoids: \u201csure it works in practice, but does it work in theory?\u201d Cancer. 2015;121(22):3933\u201337. doi: 10.1002\/cncr.29562 .","journal-title":"Cancer."},{"issue":"10","key":"6082_CR27","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1007\/s00256-016-2439-y","volume":"45","author":"PJ Sheth","year":"2016","unstructured":"Sheth PJ, del Moral S, Wilky BA, et al. Desmoid fibromatosis: MRI features of response to systemic therapy. Skelet Radiol. 2016;45(10):1365\u201373. doi: 10.1007\/s00256-016-2439-y .","journal-title":"Skelet Radiol"},{"issue":"2","key":"6082_CR28","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1148\/radiol.2512081403","volume":"251","author":"S Stacchiotti","year":"2009","unstructured":"Stacchiotti S, Collini P, Messina A, et al. High-grade soft-tissue sarcomas: tumor response assessment\u2014pilot study to assess the correlation between radiologic and pathologic response by using RECIST and Choi criteria. Radiology. 2009;251(2):447\u201356. doi: 10.1148\/radiol.2512081403 .","journal-title":"Radiology"},{"issue":"4","key":"6082_CR29","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1007\/s00261-017-1212-6","volume":"115","author":"C Kim","year":"2017","unstructured":"Kim C, Byun JH, Hong S-M, et al. A comparison of enhancement patterns on dynamic enhanced CT and survival between patients with pancreatic neuroendocrine tumors with and without intratumoral fibrosis. Abdom Radiol. 2017;115(4):741\u201348. doi: 10.1007\/s00261-017-1212-6 .","journal-title":"Abdom Radiol"},{"issue":"4","key":"6082_CR30","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1097\/RLI.0000000000000123","volume":"50","author":"JH Yoon","year":"2015","unstructured":"Yoon JH, Lee JM, Klotz E, et al. Estimation of hepatic extracellular volume fraction using multiphasic liver computed tomography for hepatic fibrosis grading. Investig Radiol. 2015;50(4):290\u201396. doi: 10.1097\/RLI.0000000000000123 .","journal-title":"Investig Radiol"}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1245\/s10434-017-6082-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-017-6082-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-017-6082-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,3]],"date-time":"2019-10-03T05:29:23Z","timestamp":1570080563000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1245\/s10434-017-6082-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,8]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["6082"],"URL":"https:\/\/doi.org\/10.1245\/s10434-017-6082-1","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,9,8]]}}}